SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

RPG LIFE SCIENCES

BSE: 532983 09 Sep 2025
Healthcare
₹ 2372.9
RPG Life Sciences Limited specializes in Pharmaceuticals within the Healthcare sector.

RPG LIFE SCIENCES - Share Price & Details

Market Cap
₹3,931
High /Low
2,977 / 1,772
Stock P/E
38.0
Book Value
₹321.0
Dividend Yield
0.84
ROCE
32.8
ROE
₹25.5
Face Value
8.0
PEG Ratio
1.21
EVEBITDA
₹22.1
Debt
0.00
CMP / FCF
50.0
Debt to equity
₹0.0
NP Ann
183
High price all time
2,977
Piotroski score
₹7.0
Graham Number
893.0
No. Eq. Shares
1.65
Net CF
₹8.98
Net profit
183
Price to book value
7.4
Interest Coverage
₹251.0
Low price all time
15.2
Industry PE
33.4
Reserves
₹517
Free Cash Flow
₹151

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,NANANANA0
RPG LIFE SCIENCES LTD.1741.5262.91689.203,93138.0
Advanced Enzyme Technologies L1788.76739.811250.246.61387128.3
VIMTA LABS LTD.993.13188.94975.644.21365060.0

Peer Comparison Chart


About RPG LIFE SCIENCES

RPG Life Sciences Limited, with Security Code 532983, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Drug formulations firm RPG Life Sciences eyes inorganic growth

(12 Aug 2025)
Pharmaceutical formulations company RPG Life Sciences Ltd, part of the Harsh Goenka-led RPG Group, is outlining its ...
Read more →

Technical Analysis: RPG Life Sciences Limited (RPGLIFE) - Get insider insights into market trends

(06 Aug 2025)
Technical Analysis: RPG Life Sciences Limited (RPGLIFE) ✌️【Investor Trends】✌️ Our expert-picked stocks have delivered over 200% returns...
Read more →

RPG Life Sciences appoints Deepak Shukla as Chief Executive - API Business

(31 Jul 2025)
Deepak has around 25 years of work experience with reputed companies viz. UPL Group, Teva Group, AkzoNobel India, Ranbaxy Laboratories,...
Read more →

RPG Life Sciences Q1 FY2026 PAT slips to Rs. 26.29 Cr

(30 Jul 2025)
RPG Life Sciences has reported total income of Rs. 174.15 crores during the period ended June 30, 2025.
Read more →

RPG Life Sciences Q1 Revenue Rises 2.1% YoY to ₹168.9 Cr

(30 Jul 2025)
RPG Life Sciences announces Q1 FY26 results: Revenue up 2.1% YoY to ₹168.9 Cr with 24.1% EBITDA margin. PBT stable at ₹35.4 Cr. Exploring...
Read more →

RPG Life Sciences Ltd Q1 FY2026 PAT slips to Rs. 26.29 crores

(26 Jul 2025)
Shares of RPG Life Sciences Limited was last trading in BSE at Rs. 2481.35 as compared to the previous close of Rs. 2515.25. The total number of...
Read more →

Company Updates